7:15 – 8:15 am
MORNING NETWORKING
8:10 – 8:30 am
MISSION, GOALS AND OBJECTIVES OF RAISE 2026
Chairs: M. Edip Gurol (Neurology, MGB/HMS)
8:30 - 10:05 am
SESSION 1: ARTIFICIAL INTELLIGENCE IN STROKE PREVENTION
Co-Chairs: Cheryl Bushnell (Neurologist, Wake Forest)
8:15 – 8:27 am FROM COST TO DIVIDEND: THE CASE FOR INVESTING IN BIOMEDICAL
INNOVATION AND PREVENTION
Ugur Ozdemir (Quantitative Scientist, Univ. Edinburgh)
8:27 – 8:39 am AI-BASED ALGORITHMS FOR CLINICAL DECISION MAKING
Halil Tanboga (Interventional Cardiologist, Atlas Univ)
8:39 – 8:51 am AI-POWERED DEVICES FOR DIAGNOSTICS/SCREENING
TBA
8:51 – 9:03 am AI AND BIG DATA IN STROKE PREVENTION RESEARCH
Nassir Marrouche(Cardiac EP, Tulane Univ.)
9:03 – 9:09 am TBA
9:09 – 9:15 am TBA
9:15 – 10:05 am PANEL DISCUSSION
10:05 – 10:25 am
BREAK
10:25 – 12:15 pm
SESSION 2: ATRIAL FIBRILLATION DETECTION
Co-Chairs: TBA
10:25 – 10:37 am AF MONITORING WITH EXTERNAL DEVICES
TBA
10:37 – 10:49 am INSERTABLE CARDIAC MONITORS
Suneet Mittal (Cardiac EP, Valley Health System, NY)
10:49 – 11:01 am INTEGRATING DIFFERENT METHODS FOR BEST YIELD IN
PRIMARY & SECONDARY PREVENTION
TBA
11:01 – 11:13 am GLP-1 RECEPTOR AGONISTS AND SGLT-2 INHIBITORS FOR STROKE
PREVENTION
Eda Cengiz (Endocrinology, UCSF)
11:13 – 11:19 am TBA
11:19 – 11:25 am TBA
11:25 – 12:15 pm PANEL DISCUSSION
12:15 – 1:15 pm
BREAK
1:15 – 3:05 pm
SESSION 3: PREVENTING STROKE AND COGNITIVE IMPAIRMENT IN ATRIAL FIBRILLATION WITHOUT INCREASING BLEEDING RISK EXCESSIVELY
Co-Chairs: Dawn Kleindorfer (Neurology, U. Michigan)
1:15 – 1:27 pm UNDERSTANDING HEMORRHAGE RISK AND ITS IMPACT IN
AF MANAGEMEN
M. Edip Gurol(Neurology, MGB/HMS)
1:27 – 1:39 pm FACTOR XIA INHIBITORS IN AFIB
TBA
1:39 – 1:51 pm LEFT ATRIAL APPENDAGE CLOSURE (LAAC) FOR STROKE PREVENTION IN
AFIB: A DEEP DIVE IN NEW RCT RESULTS
TBA
1:51 – 2:03 pm COMBINING ABLATION AND LAAC: IMPACT ON STROKE PREVENTION
TBA
2:03 – 2:09 pm TBA
2:09 – 2:15 pm TBA
2:15 – 3:05 pm PANEL DISCUSSION
3:05 – 3:20 pm
BREAK
3:20 – 5:10 pm
SESSION 4: UPDATES ON ANTITHROMBOTICS IN STROKE PREVENTION: FOCUS ON FACTOR XIA INHIBITORS
Co-Chairs: TBA
3:20 – 3:32 pm UNDERSTANDING OUR FAILURES IN SECONDARY STROKE
PREVENTION AND THE NEED FOR NEW STRATEGIES
M. Edip Gurol(Neurology, MGB/HMS)
3:32 – 3:44 pm THE CONCEPT OF “HEMOSTASIS-SPARING”
ANTITHROMBOTICS:FACTOR XIA INHIBITION AND
BEYOND
Jeffrey Weitz (McMasters)
3:44 – 3:56 pm A DEEP DIVE IN OCEANIC-STROKE RESULTS
TBA
3:56 – 4:08 pm COMBINING FXIA INHIBITORS WITH PROCEDURAL THERAPIES
Jonathan Piccini (Duke)
4:08 – 4:14 pm TBA
4:14 – 4:20 pm TBA
4:20 – 5:10 pm PANEL DISCUSSION
6:30 – 9:30 pm
EVENING OF NETWORKING: BUILDING CONNECTIONS AND OPPORTUNITIES FOLLOWED BY SPECIAL PRESENTATION
TBA
8:15 – 8:27 am WEARABLES FOR STROKE PREVENTION
TBA
8:27 – 8:39 am AI-BASED ALGORITHMS FOR CLINICAL DECISION MAKING
TBA
8:39 – 8:51 am AI-POWERED DEVICES FOR DIAGNOSTICS/SCREENING
TBA
8:51 – 9:03 am AI AND BIG DATA IN STROKE PREVENTION RESEARCH
Nassir Marrouche (Cardiac EP, Tulane Univ.)
9:03 – 9:09 am TBA
9:09 – 9:15 am TBA
9:15 – 10:05 am PANEL DISCUSSION
Jose Merino (Neurology, Georgetown)
7:00 – 8:00 am
MORNING NETWORKING
8:00 – 9:40 am
EDITORS’ CORNER: HOW TO ENCOURAGE MULTIDISCIPLINARY STUDIES IN NEURO/CARDIO-VASCULAR MEDICINE
Participants:
Flávia Geraldes (Lancet)
Karen Furie (JNNP)
Bruce Ovbiagele (JAHA)
Hooman Kamel (JAMA Neurology)
Kalyanam Shivkumar (JACC EP), Eric Smith (Stroke)
David Wang (Stroke and Vascular Neurology)
8:40 – 10:05 am
SESSION 5: NIH AND FDA CORNER
Chair: Bruce Ovbiagele (Neurology, UCSF)
8:40 – 8:52 am FDA APPROVAL PROCESS FOR THE CARDIOVASCULAR AND
NEUROVASCULAR DEVICES
Kim Selzman (FDA Center for Devices and Radiological Health (CDRH))
8:52 – 9:04 am FDA APPROVAL PROCESS FOR DRUGS IN STROKE PREVENTION
TBA
9:04– 9:16 am TBA
9:16 – 9:28 am CLINICAL TRIALS FOR STROKE PREVENTION AT NINDS
Clinton Wright (NINDS)
9:28 – 10:05 am PANEL DISCUSSION
10:05 – 10:25 am
BREAK
10:25 – 12:15 pm
SESSION 6: UPDATES ON DEVICES FOR STROKE PREVENTION
Co-Chairs: Flávia Geraldes (Lancet)
10:25 – 10:37 am BETTER SCREENING FOR PFO: IMPLICATIONS FOR CLINICAL CARE
AND RESEARCH
TBA
10:37 – 10:49 am NEW/POTENTIAL STUDIES IN PFO Closure
Jeff Saver(Neurology, UCLA)
10:49 – 11:01 am LEFT ATRIAL APPENDAGE THROMBUS FORMATION IN PATIENTS
WITHOUT KNOWN AFIB
TBA
11:01 – 11:13 am PROPHYLACTIC ABLATION AND LAA OBLITERATION DURING MAJOR
CARDIAC SURGERY
TBA
11:13 – 11:19 am TBA
11:19 – 11:25 am TBA
11:25 – 12:15 pm PANEL DISCUSSIO
12:15 – 1:15 pm
BREAK
1:15 – 3:05 pm
SESSION 7: SPECIAL CASES IN PREVENTION OF ISCHEMIC AND HEMORRHAGIC STROKES
Co-Chairs: Karen Furie (Neurology, Brown) and Jared Bunch (Cardiac EP, Utah)
1:15 – 1:27 pm SCREENING FOR CAROTID ARTERY DISEASE IN 2026
Murat Arsava (Neurology, Atlas University)
1:27 – 1:39 pm CREST2 RESULTS AND ITS IMPLICATIONS FOR CAROTID STENTING
TBA
1:39 – 1:51 pm MULTIDISCIPLINARY APPROACH TO STROKE PREVENTION
TBA
1:51 – 2:03 pm ATRIAL FIBRILLATION AND COGNITIVE IMPAIRMENT
Rebecca Gottesman(Neurology, NINDS)
2:03 – 2:15 pm NEUROIMAGING MARKERS FOR STROKE PREVENTION TRIALS
Eric Smith(Neurology, U. Calgary)
2:15 – 3:05 pm PANEL DISCUSSION
3:05 – 3:20 pm
BREAK
3:20 – 4:30 pm
WORKSHOPS TO DEVELOP CONSENSUS RECOMMENDATIONS
Participants are divided into three groups, each to develop recommendations.
WORKSHOP #1: PREVENTION OF ISCHEMIC STROKES AND HEMORRHAGES IN ATRIAL FIBRILLATION
Moderators:
Andrea Russo (Cooper Norcross Health)
Shadi Yaghi (JSUMC)
TBA
WORKSHOP #2: CUTTING EDGE MEDICAL TREATMENTS FOR NON-AFIB STROKE PREVENTION
Moderators:
Pooja Khatri (University of Cincinnati)
John Eikelboom (University of Michigan)
Baris Alten (University of Pennsylvania)
WORKSHOP #3: UPDATES ON DEVICES FOR NON-AFIB STROKE PREVENTION
Moderators:
TBA
4:30 – 4:45 pm
BREAK
4:45 – 6:00 pm
WORKSHOP CHAIRS PRESENT RECOMMENDATIONS TO FULL ASSEMBLY
Drafting of consensus statement is initiated
Chaired by M. Edip Gurol (MGH/HMS)